Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes

BACKGROUND: Allogeneic islet transplantation has become a viable option for the treatment of unstable type 1 diabetes. However, the donor shortage and the necessity of the immunosuppressive drugs are two major issues. To solve these issues, we performed islet xenotransplantation using encapsulated n...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Shinichi, Abalovich, Adrian, Wechsler, Carlos, Wynyard, Shaun, Elliott, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078586/
https://www.ncbi.nlm.nih.gov/pubmed/27592597
http://dx.doi.org/10.1016/j.ebiom.2016.08.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078586/
https://www.ncbi.nlm.nih.gov/pubmed/27592597
http://dx.doi.org/10.1016/j.ebiom.2016.08.034

Ejemplares similares